Wound Care Fraud Prosecutions: Why Skin Substitute Billing Is the DOJ’s Top Healthcare Fraud Target
If you bill or billed Medicare for skin substitutes, amniotic grafts, or debridement procedures, you are practicing in one of the most scrutinized corners of American healthcare right now. In fact, it is specifically identified as one of the current Department of Justice enforcement priorities. Medicare Part B spending on skin substitutes grew from roughly […]
Skin Substitute and Wound Care Fraud Investigations: What Providers Need to Know in 2026
Skin substitutes and advanced wound care have quietly become one of the most aggressive enforcement areas in federal health care fraud. What began as civil audits and payment reviews has increasingly evolved into subpoenas, False Claims Act cases, and criminal investigations. I expect this trend to accelerate in 2026. In my practice, I am seeing […]
Non-jail sentence following prosecution for violation of AKS
I regularly represent health care providers, marketers, and health care organizations accused of or under investigation for health care fraud and violations of the anti-kickback statute. Recently, I represented the owner of a pharmacy. The owner was charged with engaging in a conspiracy to pay kickbacks in exchange for referrals, in addition to other crimes. The […]
Andrew Feldman and Marissel Descalzo Obtain A Judgment of Acquittal in Fraud Trial Related to Clinical Trial
Andrew S. Feldman and I obtained a rare Rule29 judgment of acquittal on the one major count at trial alleging that the client participated in a wire fraud conspiracy. The wire fraud conspiracy related entirely to the client’s supposed involvement in a fraudulent clinical trial for Asthma drugs sponsored by GlaxoSmith Kline. From 2014 until […]
A win for the defense in False Claims Act actions
In United States ex rel, Sheldon v. Allergan Sales, LLC, the relator claimed that defendant drug manufacturer had engaged in an allegedly fraudulent price reporting scheme under the Medicaid Drug Rebate Statute. Under the Rebate statute, drug manufacturers seeking to have drugs covered by Medicaid must enter into rebate agreements by which they provide quarterly […]